Form SD Vontier Corp
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM SD
Specialized Disclosure Report
Vontier Corporation
(Exact Name of Registrant as Specified in its Charter)
Delaware 001-39483 84-2783455
(State or Other Jurisdiction
of Incorporation)
(Commission
File No.)
(I.R.S. Employer
Identification Number)
5438 Wade Park Boulevard, Suite 600 ... (continue reading...)
Form 10-Q Akero Therapeutics, Inc. For: Mar 31
Q1false--12-310001744659http://fasb.org/us-gaap/2023#OperatingLeaseLiabilityNoncurrent... (continue reading...)
Form 10-Q Inspired Entertainment, For: Mar 31
false
Q1
--12-31
0001615063
0001615063
2024-01-01
2024-03-31
0001615063
2024-05-07
... (continue reading...)
Form 10-Q Wave Life Sciences Ltd. For: Mar 31
Q1--12-31false0001631574one yearfive yearsone... (continue reading...)
Form 4 PLUS THERAPEUTICS, INC. For: May 08 Filed by: HEDRICK MARC H
.FormData {
color: blue;
background-color: white;
font-size: 12px;
font-family: Times, serif;
}
.FormDataR {
color: blue;
background-color: white;
font-size: 12px;
font-family: Times, serif;
text-align: right;
}
.SmallFormData {
color: blue;
background-color: white;
font-size: 10px;
font-family: Times, serif;
}
.FootnoteData {
color: green;
background-color: white;
... (continue reading...)
More SEC Filings
View Older Stories-
Form 4 PLUS THERAPEUTICS, INC. For: May 08 Filed by: Sims Andrew John Hugh MacIntyre
-
Form 8-K OVERSEAS SHIPHOLDING For: May 10
-
Form 4 PLUS THERAPEUTICS, INC. For: May 08 Filed by: Clowes Howard
-
Form DEFR14A SHF Holdings, Inc.
-
Form 4 PLUS THERAPEUTICS, INC. For: May 08 Filed by: Petersen Greg
-
Form 4 PLUS THERAPEUTICS, INC. For: May 08 Filed by: Hawkins Richard J
-
Form 4 PLUS THERAPEUTICS, INC. For: May 08 Filed by: Lenk Robert P
-
Form 4 Westlake Chemical Partne For: May 08 Filed by: Kenner Andrew
-
Form 10-Q American Strategic Inves For: Mar 31
-
Form 10-Q Deciphera Pharmaceutical For: Mar 31
-
Form 8-K United Homes Group, Inc. For: May 10
-
Form 8-K American Strategic Inves For: May 10
-
Form D/A Parsifal Offshore Ltd.
-
Form 13F-HR HOMESTEAD ADVISERS CORP For: Mar 31
-
Form 8-K Star Holdings For: May 10
-
Form 10-Q Protalix BioTherapeutics For: Mar 31
-
Form D/A Parsifal Fund, LP
-
Form 8-K Douglas Elliman Inc. For: May 09
-
Form 8-K Akero Therapeutics, Inc. For: May 10
-
Form 8-K SANUWAVE Health, Inc. For: May 10
-
Form SD BECTON DICKINSON & CO
-
Form D/A Parsifal Master Fund
-
Form 8-K Sylvamo Corp For: May 10
-
Form 8-K Inspired Entertainment, For: May 10
-
Form 8-K Workhorse Group Inc. For: May 10
-
Form 10-Q Star Holdings For: Mar 31
-
Form 13F-HR Banco Santander, S.A. For: Mar 31
-
Form 6-K Crescent Point Energy For: May 10
-
Form 10-Q Luminar Technologies, For: Mar 31
-
Form 10-Q Instil Bio, Inc. For: Mar 31
-
Form 8-K Aeluma, Inc. For: May 10
-
Form 10-Q ANI PHARMACEUTICALS INC For: Mar 31
-
Form 8-K Mondee Holdings, Inc. For: May 10
-
Form D CR-0318 Fund II, a serie
-
Form 13F-NT Grupo Empresarial Santan For: Mar 31
-
Form D/A Dark Forest Global Equit
-
Form 13F-HR Intermede Investment For: Mar 31
-
Form 8-K Humacyte, Inc. For: May 10
-
Form 8-K i3 Verticals, Inc. For: May 10
-
Form 8-K PROKIDNEY CORP. For: May 10
-
Form 8-K TruBridge, Inc. For: May 10
-
Form 424B3 Goodness Growth Holdings
-
Form 10-Q ENBRIDGE INC For: Mar 31
-
Form 6-K Crescent Point Energy For: Mar 31
-
Form 10-Q DigitalOcean Holdings, For: Mar 31
-
Form 424B3 Goodness Growth Holdings
-
Form 8-K Ubiquiti Inc. For: May 10
-
Form D/A Dark Forest Global Equit
-
Form 8-K AMC Networks Inc. For: May 10
-
Form 8-K DigitalOcean Holdings, For: May 10
